Phreesia, Inc. ( PHR ) Nowojorska Giełda Papierów Wartościowych

Cena: 28.99 ( -0.31% )

Aktualizacja 07-03 22:00
Nowojorska Giełda Papierów Wartościowych
Branża: Medical - Healthcare Information Services

Notowania:


Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Healthcare Information Services
Zatrudnienie: 1 438
Giełda: Nowojorska Giełda Papierów Wartościowych
Ilość akcji w obrocie: 94%
Ilość akcji: 55 634 900
Debiut giełdowy: 2019-07-18
WWW: https://www.phreesia.com
CEO: Mr. Chaim Indig
Adres: 434 Fayetteville Street
Siedziba: 27601 Raleigh
ISIN: US71944F1066
Opis firmy:

Phreesia, Inc. zapewnia zintegrowaną platformę oprogramowania i płatności opartą na SaaS dla branży opieki zdrowotnej w Stanach Zjednoczonych i Kanadzie. Platforma Phreesia oferuje pakiet rozwiązań do zarządzania procesem przyjmowania pacjenta, a także zintegrowane rozwiązanie płatności w celu przetwarzania płatności pacjentów. Firma wdraża swoją platformę w różnych metodach, takich jak Phreesia Mobile, urządzenie mobilne pacjentów; Phreesia Dashboard, internetowy pulpit nawigacyjny dla klientów usług opieki zdrowotnej; Freesiapady, które są tabletkami do spożycia samoobsługowego; i przybysze kioski, które są kioskami na miejscu. Platforma Phreesia zapewnia również rozwiązanie rejestracyjne w celu zautomatyzowania samorejestracji pacjenta; Rozwiązanie cyklu przychodów, które oferuje procesy weryfikacji ubezpieczeniowej, aplikacje płatności w punkcie sprzedaży i narzędzia szacowania kosztów; Dostęp do rozwiązań, które oferują system planowania terminów na spotkania online, przypomnienia i śledzenie poleceń; oraz rozwiązanie nauk przyrodniczych w celu zapewnienia pacjentom ukierunkowane i klinicznie istotne treści marketingowe. Ponadto platforma Phreesia firmy oferuje rozwiązanie wsparcia klinicznego, które gromadzi dane dotyczące spożycia klinicznego i zgłoszone przez pacjenta dane dotyczące wyników (Pro) dla około 25 specjalności, a także umożliwia klientom usług opieki zdrowotnej komunikowanie się z pacjentami poprzez ankiety, ogłoszenia, wiadomości tekstowe i e -mail oraz kampanie zdrowotne; oraz moduły wsparcia COVID-19 w zarządzaniu dostarczaniem szczepionki COVID-19 i identyfikowania pacjentów-hesitantów szczepionek, badania przesiewowe pod kątem zgłoszonych czynników ryzyka Covid-19, umożliwiając zameldowanie kontaktu podczas wizyt osobistych oraz zbieranie informacji o przyjmowaniu podczas wizyt telezdrowia. Służy pacjentom; Praktyki jednorazowe, grupy wielo specjalizacyjne i systemy opieki zdrowotnej; oraz firmy farmaceutyczne, medyczne i biotechnologiczne. Firma została zarejestrowana w 2005 roku i ma siedzibę w Raleigh w Karolinie Północnej.

Wskaźniki finansowe
Kapitalizacja (USD) 1 725 029 657
Aktywa: 362 235 000
Cena: 28.99
Wskaźnik Altman Z-Score: 4.3
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 0
P/E: -39.2
Ilość akcji w obrocie: 94%
Średni wolumen: 561 249
Ilość akcji 59 504 300
Wskaźniki finansowe
Przychody TTM 389 956 000
Zobowiązania: 110 900 000
Przedział 52 tyg.: 17.07 - 30.53
Piotroski F-Score: 4
Umiarkowany (średnia jakość finansowa)
EPS: -0.7
P/E branży: 32.4
Beta: 0.947
Raport okresowy: 2025-09-02
WWW: https://www.phreesia.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. David Linetsky Senior Vice President of Life Sciences 561 802 1981
Mr. Chaim Indig Co-Founder, Chief Executive Officer & Director 495 027 1980
Mr. Evan Roberts Co-Founder & Chief Operating Officer 384 487 1980
Mr. Balaji Gandhi Chief Financial Officer 369 904 1975
Ms. Allison C. Hoffman General Counsel & Secretary 336 426 1971
Ms. Amy Beth VanDuyn Senior Vice President of Human Resources 0 1974
Ms. Yvonne Hui Vice President & Principal Accounting Officer 0 1981
Mr. Ashwin G. Uttamchandani Vice President of Sales & Marketing Operations 0 0
Mr. Jack Callahan Chief Technology Officer 0 0
Ms. Maureen McKinney Vice President of Corporate Communications 0 0
Wiadomości dla Phreesia, Inc.
Tytuł Treść Źródło Aktualizacja Link
Phreesia Sets Release Date for Fiscal First Quarter 2026 Results ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal first quarter 2026 financial results after the close of market trading on Wednesday, May 28, 2025. businesswire.com 2025-04-29 10:40:00 Czytaj oryginał (ang.)
Wall Street Analysts Think Phreesia (PHR) Could Surge 28.02%: Read This Before Placing a Bet The consensus price target hints at a 28% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com 2025-04-04 14:55:27 Czytaj oryginał (ang.)
Phreesia Maintains Its Momentum Phreesia remains resilient, maintaining guidance and showing strong financial performance, with Q4 revenue growth of 15% year-over-year and improved cash flow. Despite a slight deceleration in customer growth, Phreesia's revenue per healthcare services client increased, driven by network solutions, and the company expects 13.6% revenue growth in fiscal 2026. Future growth drivers include patient education initiatives and Post-Script Engagement, while competition is seen as beneficial, enhancing market awareness and adoption of healthcare solutions. seekingalpha.com 2025-03-16 11:00:57 Czytaj oryginał (ang.)
Phreesia Named to G2's List of 2025 Best Healthcare Software Products ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named to G2's 2025 Best Software Awards in the Best Healthcare Software Products category. businesswire.com 2025-03-13 18:06:00 Czytaj oryginał (ang.)
Phreesia, Inc. (PHR) Q4 2025 Earnings Call Transcript Phreesia, Inc. (NYSE:PHR ) Q4 2025 Earnings Conference Call March 12, 2025 5:00 PM ET Company Participants Balaji Gandhi - CFO Chaim Indig - Co-Founder, CEO & Director Conference Call Participants Anne Samuel - JPMorgan Jessica Tassan - Piper Sandler Jailendra Singh - Triust Securities Ryan Daniels - William Blair Richard Close - Canaccord Genuity Ryan MacDonald - Needham & Company Jeff Garro - Stephens Daniel Grosslight - Citi Group Scott Schoenhaus - KeyBanc Capital Markets Operator Good evening, ladies and gentlemen, and welcome to Phreesia's Fourth Quarter Fiscal 2025 Earnings Conference Call. [Operator Instructions] First, I would like to introduce Balaji Gandhi, Phreesia's Chief Financial Officer. seekingalpha.com 2025-03-12 22:30:21 Czytaj oryginał (ang.)
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates Phreesia (PHR) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.56 per share a year ago. zacks.com 2025-03-12 20:16:14 Czytaj oryginał (ang.)
Phreesia Announces Fourth Quarter Fiscal 2025 Results ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2025. "We are pleased with our solid finish to fiscal 2025 and I am excited about the new products we have introduced over the past several quarters that improve medication adherence and the overall patient and provider experience," said CEO and Co-Founder Chaim Indig. Please visit the Phr. businesswire.com 2025-03-12 18:03:00 Czytaj oryginał (ang.)
Phreesia (PHR) Moves 5.6% Higher: Will This Strength Last? Phreesia (PHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. zacks.com 2025-02-14 10:06:11 Czytaj oryginał (ang.)
Phreesia's Sally Thayer Selected as a Top Woman Leader in Software ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that Sally Thayer, VP of Product Management, is a winner for The Software Report's 2024 list of Top 50 Women Leaders in Software. businesswire.com 2025-02-11 08:48:00 Czytaj oryginał (ang.)
Phreesia Sets Release Date for Fiscal Fourth Quarter and Fiscal Year 2025 Results ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal fourth quarter and fiscal year 2025 financial results after the close of market trading on Wednesday, March 12. businesswire.com 2025-02-07 18:15:00 Czytaj oryginał (ang.)
Phreesia, Inc. (PHR) Soars to 52-Week High, Time to Cash Out? Phreesia (PHR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com 2025-01-29 12:16:26 Czytaj oryginał (ang.)
Zacks Industry Outlook Enovis, Omnicell and Phreesia Enovis, Omnicell and Phreesia have been highlighted in this Industry Outlook article. zacks.com 2025-01-24 04:51:10 Czytaj oryginał (ang.)
3 Medical Info Systems Stocks to Buy as Stargate AI Drives Industry Prospects Zacks Medical Info Systems industry stocks like Enovis, Omnicell and Phreesia are expected to gain from the GenAI wave. zacks.com 2025-01-23 14:21:13 Czytaj oryginał (ang.)
Phreesia (PHR) Upgraded to Buy: Here's Why Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com 2025-01-14 15:00:34 Czytaj oryginał (ang.)
Should You Buy Phreesia (PHR) After Golden Cross? From a technical perspective, Phreesia, Inc. (PHR) is looking like an interesting pick, as it just reached a key level of support. PHR's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world. zacks.com 2025-01-08 13:06:27 Czytaj oryginał (ang.)
Wall Street Analysts See a 25% Upside in Phreesia (PHR): Can the Stock Really Move This High? The consensus price target hints at a 25% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com 2024-12-20 12:56:17 Czytaj oryginał (ang.)
Phreesia Has Turned The Corner, Can It Continue To Mend? Phreesia's Q3 earnings show solid revenue growth, but customer growth is decelerating, impacting overall performance. Fiscal 2025 guidance improved with higher EBITDA and tighter revenue estimates, while fiscal 2026 projects slower revenue growth but significant EBITDA improvement. Strong cash flow and disciplined expense management are encouraging, with the company maintaining positive cash flows and holding $82M in cash. seekingalpha.com 2024-12-12 08:44:38 Czytaj oryginał (ang.)
Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript seekingalpha.com 2024-12-09 21:22:05 Czytaj oryginał (ang.)
Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Phreesia (PHR) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2024-12-09 21:00:32 Czytaj oryginał (ang.)
Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates Phreesia (PHR) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.58 per share a year ago. zacks.com 2024-12-09 20:20:30 Czytaj oryginał (ang.)
Phreesia Announces Third Quarter Fiscal 2025 Results ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2024. "We are excited about the future here at Phreesia,” said CEO and Co-Founder Chaim Indig. “Our network continues to grow, adoption of our current offerings is increasing, and we are beginning to see the promise of new solutions we are investing in.” Please visit the Phreesia investor relations website. businesswire.com 2024-12-09 18:05:00 Czytaj oryginał (ang.)
North American Morning Briefing : Global Ad Shares -2- Lundin Mining Announces Sale to Boliden of its Neves-Corvo operation in Portugal and Zinkgruvan operation in Sweden for Up to $1.52 Billion: Lundin To Receive Upfront Cash Consideration of $1.37B Upon Closing; To Also Get up to $150M in Contingent Cash Upon Satisfaction of Condition; Proceeds Will Strengthen Balance Sheet and Support Growth Plans in the Vicuña District Expected Major Events for Monday aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); 00:01/UK: Nov KPMG and REC UK Report on Jobs 04:30/JPN: Nov Corporate Insolvencies 05:00/JPN: Nov Economy Watchers Survey 07:00/GER: 3Q Labour cost index 15:00/US: Oct Monthly Wholesale Trade 15:00/US: Nov Employment Trends Index 23:50/JPN: Nov Money Stock, Broadly-defined Liquidity All times in GMT. Powered by Kantar Media and Dow Jones. Expected Earnings for Monday Amtech Systems Inc (ASYS) is expected to report $-0.01 for 4Q. Anavex Life Sciences Corp (AVXL) is expected to report $-0.16 for 4Q. Avalon Advanced Materials is expected to report for 4Q. Braze Inc (BRZE) is expected to report $-0.30 for 3Q. Buckle Inc (BKE) is expected to report. C3.ai Inc (AI) is expected to report $-0.60 for 2Q. Casey's General Stores Inc (CASY) is expected to report $4.25 for 2Q. Centene Corp (CNC) is expected to report for Full year. Digital Ally Inc (DGLY) is expected to report for 3Q. Franklin Resources Inc (BEN) is expected to report. Genasys Inc (GNSS) is expected to report $-0.11 for 4Q. Healthequity Inc (HQY) is expected to report $0.24 for 3Q. MongoDB Inc (MDB) is expected to report $-0.83 for 3Q. NexPoint Diversified Real Estate Trust (NXDT) is expected to report for 3Q. North West Co Inc (NWC.T) is expected to report $0.77 for 3Q. Oil-Dri Corp of America (ODC) is expected to report for 1Q. Oracle Corp (ORCL) is expected to report $1.06 for 2Q. Phreesia Inc (PHR) is expected to report $-0.27 for 3Q. Planet Labs PBC (PL) is expected to report $-0.08 for 3Q. Remark Holdings Inc (MARK) is expected to report $-0.19 for 3Q. Rent the Runway Inc (RENT) is expected to report for 3Q. Smart Share Global Ltd - ADR (EM) is expected to report for 3Q. Talis Biomedical Corp (TLIS) is expected to report for 3Q. Titan Pharmaceuticals Inc (TTNP) is expected to report for 3Q. Toll Brothers Inc (TOL) is expected to report $4.34 for 4Q. Vail Resorts (MTN) is expected to report $-4.96 for 1Q. VersaBank is expected to report $0.29 for 4Q. Webco Industries Inc (WEBC) is expected to report for 1Q. Yext Inc (YEXT) is expected to report $0.06 for 3Q. Powered by Kantar Media and Dow Jones. ANALYST RATINGS ACTIONS Altria Raised to Buy From Neutral by B of A Securities Argan Cut to Market Perform From Market Outperform by CJS Securities Asana Raised to Sector Weight From Underweight by Keybanc Brixmor Property Group Raised to Outperform From Market Perform by BMO Capital Deere & Co Cut to Hold From Buy by Jefferies DocuSign Cut to Reduce From Hold by HSBC Dollar General Raised to Buy From Underperform by B of A Securities Duckhorn Portfolio Cut to Hold From Buy by Jefferies EPAM Systems Raised to Buy From Neutral by Goldman Sachs Fortrea Holdings Cut to Neutral From Outperform by Baird GrafTech International Raised to Neutral From Underweight by JP Morgan Hewlett Packard Ent Raised to Buy From Neutral by Citigroup Kennametal Cut to Hold From Buy by Jefferies Molson Coors Beverage Raised to Buy From Neutral by B of A Securities ONE Gas Cut to Neutral From Buy by Ladenburg Thalmann Paccar Cut to Hold From Buy by Jefferies Peloton Interactive Raised to Neutral From Sell by UBS PJT Partners Raised to Neutral From Sell by UBS PotlatchDeltic Raised to Outperform From Market Perform by BMO Capital ProFrac Holding Cut to Underweight From Neutral by JP Morgan Prologis Cut to Underperform From Market Perform by BMO Capital ProPetro Holding Raised to Neutral From Underweight by JP Morgan Republic Services Raised to Outperform From Market Perform by BMO Capital Robinhood Markets Raised to Buy From Neutral by Goldman Sachs SiteOne Landscape Supply Raised to Buy From Hold by Jefferies Smith & Wesson Brands Cut to Hold From Buy by Craig-Hallum Smith & Wesson Brands Cut to Hold From Buy by Lake Street Timken Raised to Buy From Hold by Jefferies WesBanco Raised to Strong Buy From Outperform by Raymond James Weyerhaeuser Raised to Outperform From Market Perform by BMO Capital This article is a text version of a Wall Street Journal newsletter published earlier today. (END) Dow Jones Newswires 12-09-24 0634ET https://www.marketscreener.com 2024-12-09 08:35:38 Czytaj oryginał (ang.)
Curious about Phreesia (PHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics Evaluate the expected performance of Phreesia (PHR) for the quarter ended October 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. zacks.com 2024-12-06 12:17:21 Czytaj oryginał (ang.)
Phreesia Named to The Software Report's “Top 100 Software Companies” for the Third Consecutive Year ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been selected by The Software Report as one of the “Top 100 Software Companies of 2024” for a third consecutive year. businesswire.com 2024-11-22 08:48:00 Czytaj oryginał (ang.)
Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last? Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. zacks.com 2024-11-07 07:31:08 Czytaj oryginał (ang.)
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024. businesswire.com 2024-11-01 08:48:00 Czytaj oryginał (ang.)
Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health EHR Expertise for its integration of the Phreesia platform. businesswire.com 2024-10-28 08:48:00 Czytaj oryginał (ang.)
Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround Phreesia (PHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. zacks.com 2024-10-10 14:35:21 Czytaj oryginał (ang.)
Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has joined the NAI to shape the national conversation around data privacy and promote consumer choice and transparency. businesswire.com 2024-10-08 10:48:00 Czytaj oryginał (ang.)
Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns ALL-REMOTE COMPANY/WILMINGTON, Del. & NEW YORK--(BUSINESS WIRE)--Phreesia has collaborated with the Ad Council to bring three public health campaigns about mental health directly to patients and caregivers. businesswire.com 2024-10-03 10:48:00 Czytaj oryginał (ang.)
Phreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) Model ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce that its contract with the CMS Innovation Center for use of the Patient Activation Measure® has been renewed to 2029. businesswire.com 2024-10-01 10:48:00 Czytaj oryginał (ang.)
Phreesia: Remain Bullish Given The Healthy Growth Outlook I maintain a buy rating for PHR, driven by strong client growth, solid revenue outlook, and increasing transaction sizes in the pipeline. PHR's 2Q25 results show 19% y/y revenue growth and improved profitability, with positive EBITDA and FCF, indicating strong financial health. Despite a slight decline in revenue per AHSC, larger client acquisitions and increased transaction sizes support my 20% growth expectation. seekingalpha.com 2024-09-05 16:19:59 Czytaj oryginał (ang.)
Phreesia, Inc. (PHR) Q2 2025 Earnings Call Transcript Phreesia, Inc. (NYSE:PHR ) Q2 2025 Earnings Conference Call September 4, 2024 5:00 PM ET Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Chief Executive Officer Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Scott Schoenhaus - KeyBanc Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Glen Santangelo - Jefferies Stephanie Davis - Barclays Joe Vruwink - Baird John Ransom - Raymond James Richard Close - Canaccord Security Daniel Grosslight - Citi Sean Dodge - RBC Capital Markets Jeff Garro - Stephens Matthew Shea - Needham & Company Jack Wallace - Guggenheim Aaron Kimson - Citizens JMP Operator Good evening, ladies and gentlemen, and welcome to the Phreesia Second Quarter Fiscal 2025 Earnings Conference Call. At this time all participants are in a listen-only mode. seekingalpha.com 2024-09-05 00:08:07 Czytaj oryginał (ang.)
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com 2024-09-04 23:01:06 Czytaj oryginał (ang.)
Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates Phreesia (PHR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.68 per share a year ago. zacks.com 2024-09-04 22:15:30 Czytaj oryginał (ang.)